UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by W.H. Cornerstone Investments Inc.

W.H. Cornerstone Investments Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,604 shares of the healthcare conglomerate’s stock after purchasing an additional 28 shares during the quarter. W.H. Cornerstone Investments Inc.’s holdings in UnitedHealth Group were worth $845,000 as of its most recent filing with the SEC.

Other large investors have also bought and sold shares of the company. Bray Capital Advisors increased its holdings in shares of UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after buying an additional 50 shares in the last quarter. Defined Wealth Management LLC raised its position in shares of UnitedHealth Group by 0.8% during the third quarter. Defined Wealth Management LLC now owns 3,406 shares of the healthcare conglomerate’s stock worth $1,717,000 after purchasing an additional 28 shares during the period. Tcwp LLC boosted its position in shares of UnitedHealth Group by 0.6% in the 3rd quarter. Tcwp LLC now owns 5,481 shares of the healthcare conglomerate’s stock valued at $2,763,000 after purchasing an additional 33 shares during the period. J.W. Cole Advisors Inc. raised its holdings in UnitedHealth Group by 4.5% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 4,708 shares of the healthcare conglomerate’s stock worth $2,374,000 after buying an additional 201 shares during the period. Finally, Channel Wealth LLC boosted its holdings in shares of UnitedHealth Group by 13.7% in the third quarter. Channel Wealth LLC now owns 6,424 shares of the healthcare conglomerate’s stock worth $3,239,000 after buying an additional 775 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on UNH. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Finally, Morgan Stanley reduced their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $0.52 during midday trading on Friday, reaching $492.45. The stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The stock has a market capitalization of $453.09 billion, a P/E ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm’s fifty day simple moving average is $482.32 and its 200-day simple moving average is $512.42.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.26 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.